소아 및 신생아 중환자 치료 장비 시장 예측(-2034년) : 장비 종류, 환자층, 유통 채널, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Pediatric & Neonatal Intensive Care Equipment Market is accounted for $10.3 billion in 2026 and is expected to reach $16.6 billion by 2034 growing at a CAGR of 6.2% during the forecast period. Pediatric & Neonatal Intensive Care Equipment refers to specialized healthcare technologies used to manage newborns, infants, and children receiving critical care. The equipment includes incubators, radiant warmers, ventilators, monitoring systems, phototherapy devices, infusion pumps, and respiratory assistance technologies. These solutions address the distinct clinical needs of younger patients through controlled thermal management, delicate respiratory support, precise drug administration, and continuous physiological observation. Innovations in compact device designs, integrated monitoring capabilities, and connected care platforms are helping healthcare professionals enhance intensive-care processes and provide more consistent and responsive treatment for critically ill pediatric and neonatal patients.

According to WHO, 13.4 million babies were born preterm worldwide in 2020, representing approximately 1 in 10 live births. Premature infants frequently require specialized neonatal care and respiratory support, supporting demand for intensive-care equipment such as incubators, ventilators, monitors, and temperature-management devices.

Market Dynamics:

Driver:

Rising prevalence of premature births and neonatal complications

Growing numbers of premature infants and newborns experiencing critical medical conditions are supporting demand for Pediatric & Neonatal Intensive Care Equipment. Such patients often need advanced ventilation, controlled temperatures, continuous physiological monitoring, and specialized nutritional support. Consequently, hospitals are investing in neonatal incubators, respiratory devices, infant warmers, phototherapy equipment, and monitoring technologies. Greater recognition of timely neonatal intervention, alongside improvements in survival outcomes, is further encouraging healthcare providers to enhance intensive care capacity and upgrade specialized infrastructure for vulnerable newborns and pediatric patients.

Restraint:

High cost of advanced intensive care equipment

Expensive pediatric and neonatal intensive-care technologies can create barriers to market expansion, especially among healthcare providers operating with constrained budgets. Equipment such as specialized ventilators, incubators, patient monitors, and infusion systems often involves significant purchasing costs. Facilities must also consider ongoing expenditures for servicing, calibration, technical support, replacement components, and personnel training. These financial pressures may cause smaller hospitals and facilities in emerging healthcare markets to postpone modernization initiatives or continue using existing equipment, reducing the pace of adoption for advanced intensive-care technologies.

Opportunity:

Expansion of neonatal and pediatric care in emerging healthcare

Developing healthcare markets offer opportunities as neonatal and pediatric medical services continue expanding. Investments in hospitals, critical-care infrastructure, and maternal-child healthcare are increasing the need for specialized equipment. Newly established or upgraded neonatal intensive care units and pediatric departments require technologies including incubators, warmers, ventilators, monitoring devices, phototherapy equipment, and infusion systems. Government-supported healthcare initiatives and broader availability of specialized treatment can encourage additional procurement. Equipment manufacturers that provide dependable, affordable, and adaptable solutions can respond to the changing needs of healthcare providers in these regions.

Threat:

Stringent regulatory and safety requirements

Strict regulatory standards and safety obligations may challenge companies operating in the Pediatric & Neonatal Intensive Care Equipment Market. Equipment intended for vulnerable infants and children requires thorough evaluation of safety, reliability, performance, and clinical suitability. Manufacturers must often complete extensive testing, documentation, certification, and approval processes before commercialization. Changes in regulatory frameworks can add further complexity and expenses. Consequently, compliance requirements may extend development timelines, increase production costs, and make market entry more difficult for smaller manufacturers competing with established pediatric and neonatal equipment providers.

Covid-19 Impact:

The COVID-19 pandemic influenced the Pediatric & Neonatal Intensive Care Equipment Market through changes in hospital resource allocation and medical-device supply. Many healthcare providers prioritized pandemic response, placing pressure on intensive-care beds, personnel, and equipment, while logistics disruptions affected device procurement. Clinical concerns regarding respiratory complications in some pediatric and neonatal patients also highlighted the importance of ventilation, monitoring, and respiratory-support technologies. Meanwhile, hospitals increased emphasis on infection prevention, remote observation, and emergency preparedness, encouraging continued development and investment in pediatric and neonatal critical-care capabilities.

The ventilators segment is expected to be the largest during the forecast period

The ventilators segment is expected to account for the largest market share during the forecast period, reflecting the essential role of respiratory support in treating critically ill young patients. Newborns, premature infants, and children experiencing respiratory distress, infections, congenital disorders, or recovery following surgery can require mechanical assistance for effective breathing and oxygen delivery. Advances in ventilation technology have enabled more patient-sensitive modes, improved synchronization, and enhanced control of respiratory parameters. Growing focus on specialized respiratory care continues to reinforce the importance of ventilators within pediatric and neonatal intensive-care environments.

The homecare settings segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the homecare settings segment is predicted to witness the highest growth rate as more specialized care moves into residential environments. Development of portable, compact, and easier-to-operate devices is supporting the management of selected pediatric and neonatal conditions at home. Demand for convenient long-term care solutions is also increasing among families and providers. Furthermore, remote patient monitoring, telehealth integration, caregiver education, and expanding home healthcare services can facilitate broader use of pediatric and neonatal equipment in home-based care environments.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by developed healthcare systems, specialized NICU infrastructure, and widespread use of advanced clinical technologies. Hospitals and pediatric facilities across the region utilize sophisticated equipment for respiratory assistance, patient monitoring, temperature management, and neonatal treatment. Demand is further supported by the need to care for premature and medically fragile newborns. According to the CDC, neonatal intensive care admissions reached 9.8% of U.S. infants in 2023, reinforcing regional equipment requirements.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR as healthcare systems expand and investments in maternal and newborn services increase. Regional initiatives are improving specialized facilities, medical technologies, workforce capabilities, and access to critical neonatal treatment. According to WHO, South-East Asian countries are strengthening national strategies for newborn and child health, including healthcare-system improvements. Such initiatives are supporting greater availability and adoption of specialized equipment across pediatric and neonatal intensive-care facilities throughout the region.

Key players in the market

Some of the key players in Pediatric & Neonatal Intensive Care Equipment Market include GE HealthCare, Drager, Medtronic, Philips, Fisher & Paykel Healthcare, Nihon Kohden, Masimo, Vyaire Medical, Becton, Dickinson and Company, Atom Medical, Fanem, Natus Medical, Inspiration Healthcare, Mindray, Phoenix Medical Systems, Nice Neotech Medical Systems, GINEVRI and ICU Medical.

Key Developments:

In April 2026, GE HealthCare announced an expanded collaboration with DeepHealth, Inc, to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools. The announcement coincides with the Society of Breast Imaging (SBI) Annual Symposium, where GE HealthCare will showcase its latest advancements in breast imaging and women's health.

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In October 2025, Philips Healthcare and Getinge have formed a new commercial partnership in Europe to offer customers easier access to a complete anesthesia and monitoring solution. By combining Philips' monitoring solutions with Getinge's leading anesthesia care products, the partnership provides a single point of contact for purchasing and support, helping clinicians deliver high-quality care in the operating room.

Equipment Types Covered:

• Ventilators
• Incubators
• Monitors
• Infusion Pumps
• Phototherapy Equipment
• Resuscitation Devices
• Humidifiers & Oxygen Therapy Equipment
• Temperature Management Devices

Patient Groups Covered:

• Neonates (0-28 days)
• Infants (1-12 months)
• Pediatrics (1-12 years)

Distribution Channels Covered:

• Direct Institutional Sales
• Retail & Pharmacy Sales
• Online Platforms

End Users Covered:

• Hospitals
• Ambulatory Surgical Centers
• Homecare Settings

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Pediatric & Neonatal Intensive Care Equipment Market, By Equipment Type

• 5.1 Ventilators
• 5.2 Incubators
• 5.3 Monitors
• 5.4 Infusion Pumps
• 5.5 Phototherapy Equipment
• 5.6 Resuscitation Devices
• 5.7 Humidifiers & Oxygen Therapy Equipment
• 5.8 Temperature Management Devices

6 Global Pediatric & Neonatal Intensive Care Equipment Market, By Patient Group

• 6.1 Neonates (0-28 days)
• 6.2 Infants (1-12 months)
• 6.3 Pediatrics (1-12 years)

7 Global Pediatric & Neonatal Intensive Care Equipment Market, By Distribution Channel

• 7.1 Direct Institutional Sales
• 7.2 Retail & Pharmacy Sales
• 7.3 Online Platforms

8 Global Pediatric & Neonatal Intensive Care Equipment Market, By End User

• 8.1 Hospitals
• 8.2 Ambulatory Surgical Centers
• 8.3 Homecare Settings

9 Global Pediatric & Neonatal Intensive Care Equipment Market, By Geography

• 9.1 North America
  • 9.1.1 United States
  • 9.1.2 Canada
  • 9.1.3 Mexico
• 9.2 Europe
  • 9.2.1 United Kingdom
  • 9.2.2 Germany
  • 9.2.3 France
  • 9.2.4 Italy
  • 9.2.5 Spain
  • 9.2.6 Netherlands
  • 9.2.7 Belgium
  • 9.2.8 Sweden
  • 9.2.9 Switzerland
  • 9.2.10 Poland
  • 9.2.11 Rest of Europe
• 9.3 Asia Pacific
  • 9.3.1 China
  • 9.3.2 Japan
  • 9.3.3 India
  • 9.3.4 South Korea
  • 9.3.5 Australia
  • 9.3.6 Indonesia
  • 9.3.7 Thailand
  • 9.3.8 Malaysia
  • 9.3.9 Singapore
  • 9.3.10 Vietnam
  • 9.3.11 Rest of Asia Pacific
• 9.4 South America
  • 9.4.1 Brazil
  • 9.4.2 Argentina
  • 9.4.3 Colombia
  • 9.4.4 Chile
  • 9.4.5 Peru
  • 9.4.6 Rest of South America
• 9.5 Rest of the World (RoW)
  • 9.5.1 Middle East
    • 9.5.1.1 Saudi Arabia
    • 9.5.1.2 United Arab Emirates
    • 9.5.1.3 Qatar
    • 9.5.1.4 Israel
    • 9.5.1.5 Rest of Middle East
  • 9.5.2 Africa
    • 9.5.2.1 South Africa
    • 9.5.2.2 Egypt
    • 9.5.2.3 Morocco
    • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

• 10.1 Industry Value Network and Supply Chain Assessment
• 10.2 White-Space and Opportunity Mapping
• 10.3 Product Evolution and Market Life Cycle Analysis
• 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

• 11.1 Mergers and Acquisitions
• 11.2 Partnerships, Alliances, and Joint Ventures
• 11.3 New Product Launches and Certifications
• 11.4 Capacity Expansion and Investments
• 11.5 Other Strategic Initiatives

12 Company Profiles

• 12.1 GE HealthCare
• 12.2 Drager
• 12.3 Medtronic
• 12.4 Philips
• 12.5 Fisher & Paykel Healthcare
• 12.6 Nihon Kohden
• 12.7 Masimo
• 12.8 Vyaire Medical
• 12.9 Becton, Dickinson and Company
• 12.10 Atom Medical
• 12.11 Fanem
• 12.12 Natus Medical
• 12.13 Inspiration Healthcare
• 12.14 Mindray
• 12.15 Phoenix Medical Systems
• 12.16 Nice Neotech Medical Systems
• 12.17 GINEVRI
• 12.18 ICU Medical